Breaking News Instant updates and real-time market news.

POM

Pepco Holdings

, EXC

Exelon

$33.09

0.34 (1.04%)

16:35
10/18/16
10/18
16:35
10/18/16
16:35

Pepco president: $27.1M in benefits approved for Delmarva customers, public

Delmarva Power residential and business customers will gain an additional $27.1M in benefits from the company's completed merger with Exelon (EXC) under a decision by state regulators, bringing the total value of benefits to more than $72M. The additional benefits in Delaware include more funds to support energy efficiency programs to help customers save money, economic development initiatives to spark business growth and assistance for low-income residents in paying their utility bills. "These new benefits will have a positive impact on customers, communities and the economy," said Pepco Holdings (POM) President Dave Velazquez. "As part of the Exelon family, Delmarva Power - led by Region President Gary Stockbridge - is stronger and better equipped to power the business community with reliable, affordable and sustainable energy. And this is on top of the previously agreed-upon package of merger benefits." "Through the merger, we're bringing a higher level of performance and innovation to customers and the communities we serve," said Chris Crane, president and CEO, Exelon. "The additional benefits in Delaware are further proof that we will deliver on our commitments, and that together we can deliver a leading-edge, modern energy system for our customers." Today's order from the Delaware Public Service Commission provides $27.1M in benefits to Delmarva Power customers and the public, in addition to the more than $45M in benefits in the original merger package. As part of the approval of the merger, Exelon, Delmarva Power and other parties including the Staff of the Public Service Commission, the Division of Public Advocate, and the Division of Natural Resources and Environmental Control agreed to increase the value of the state's merger benefits to make them commensurate with other jurisdictions. The Public Service Commission approved that agreement, and the additional benefits announced today are the result.

POM

Pepco Holdings

EXC

Exelon

$33.09

0.34 (1.04%)

POM Pepco Holdings

03/01/16
EVER
03/01/16
NO CHANGE
EVER
Pepco Holdings standalone target price is $20 at Evercore ISI
Evercore ISI analyst Greg Gordon reiterated his Pepco (POM) standalone target price of $20 per share, is "downside" case in the event the Exelon (EXC) merger doesn't happen. Gordon's base case target price assumes a 50/50 probability of the deal closing and is now $23.50, down from $25.50, which assumed the transaction would be completed. The analyst has a Hold rating on Pepco shares.
02/23/16
SBSH
02/23/16
DOWNGRADE
Target $27
SBSH
Sell
Exelon downgraded to Sell from Neutral at Citi
Citi analyst Praful Mehta downgraded Exelon (EXC) to Sell saying the Pepco Holdings (POM) deal is "value destructive." While Pepco adds $5B of equity value, it also adds $4B of additional parent net debt and 58M shares, Mehta tells inventors in a research note. He has a $27 price target for Exelon shares.
EXC Exelon
$33.09

0.34 (1.04%)

10/04/16
SBSH
10/04/16
NO CHANGE
SBSH
Sell
Citi sees more downside in Exelon, FirstEnergy
Citi analyst Praful Mehta reiterates Sell ratings on shares of Exelon (EXC) and FirstEnergy (FE). The analyst lowered his price target for Exelon to $27 from $29 and for FirstEnergy to $29 from $31. Exelon needs external support for its nuclear units to extend asset life and improve valuations while FirstEnergy has "significant challenges" around its credit and underfunded pension, Mehta tells investors in a research note. He see further share downside in both names.
07/22/16
07/22/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cigna (CI) upgraded to Conviction Buy from Buy at Goldman with analyst Matthew Borsch saying saying shares are undervalued and sees upside potential in capital redeployment capacity. 2. Exelon (EXC) upgraded to Buy from Hold at Deutsche Bank with analyst Jonathan Arnold saying the company is a "cheap play on regulated assets with catalysts." 3. UnitedHealth (UNH) upgraded to Buy from Hold at Argus with the firm saying it thinks that the company's decision to exit the Affordable Care Act exchanges next year will boost its Earnings Per Share in 2017, and it thinks that the outlook for the company's Optum businesses is "favorable." 4. Sherwin-Williams (SHW) upgraded to Buy from Outperform at CLSA with analyst Nils-Bertil Wallin citing valuation and sustainable long-term growth. 5. Viacom (VIAB) upgraded to Neutral from Underweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/22/16
DBAB
07/22/16
UPGRADE
Target $39
DBAB
Buy
Exelon upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Jonathan Arnold upgraded Exelon to Buy saying the company is a "cheap play on regulated assets with catalysts." The analyst raised his price target for the shares to $39 from $36.
07/22/16
DBAB
07/22/16
UPGRADE
DBAB
Buy
Exelon upgraded to Buy from Hold at Deutsche Bank

TODAY'S FREE FLY STORIES

ELLI

Ellie Mae

$110.72

1.55 (1.42%)

16:43
04/27/17
04/27
16:43
04/27/17
16:43
Earnings
Ellie Mae reports Q1 adjusted EPS 25c, consensus 21c »

Reports Q1 revenue $93M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 10

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

FII

Federated Investors

$28.08

0.18 (0.65%)

16:43
04/27/17
04/27
16:43
04/27/17
16:43
Earnings
Federated Investors reports Q1 EPS 49c, consensus 46c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 28

    Apr

HLS

HealthSouth

$43.50

0.03 (0.07%)

16:43
04/27/17
04/27
16:43
04/27/17
16:43
Earnings
HealthSouth reports Q1 adjusted EPS 70c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 04

    May

LUV

Southwest

$55.75

-1.19 (-2.09%)

, AAL

American Airlines

$43.98

-2.42 (-5.22%)

16:43
04/27/17
04/27
16:43
04/27/17
16:43
General news
On The Fly: Top stock stories for Thursday »

Stocks began the session…

LUV

Southwest

$55.75

-1.19 (-2.09%)

AAL

American Airlines

$43.98

-2.42 (-5.22%)

UAL

United Continental

$70.70

-0.63 (-0.88%)

CMCSA

Comcast

$39.59

0.8 (2.06%)

CMCSK

Comcast

UPS

UPS

$108.83

1.21 (1.12%)

PYPL

PayPal

$47.15

2.74 (6.17%)

UAA

Under Armour

$21.67

1.96 (9.94%)

F

Ford

$11.47

-0.13 (-1.12%)

DOW

Dow Chemical

$63.19

-1.14 (-1.77%)

SNCR

Synchronoss

$13.29

-11.33 (-46.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 04

    May

  • 04

    May

  • 09

    May

  • 09

    May

  • 11

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 19

    May

  • 31

    May

  • 31

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

IVC

Invacare

$13.25

0.2 (1.53%)

16:42
04/27/17
04/27
16:42
04/27/17
16:42
Hot Stocks
Invacare reports completion of consent decree milestones »

Invacare reported it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 18

    May

VCRA

Vocera

$24.96

0.42 (1.71%)

16:41
04/27/17
04/27
16:41
04/27/17
16:41
Earnings
Vocera sees Q2 adjusted EPS (8c)-(3c), consensus 2c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 17

    May

  • 30

    May

BNFT

Benefitfocus

$30.85

0.9 (3.01%)

16:41
04/27/17
04/27
16:41
04/27/17
16:41
Earnings
Benefitfocus sees FY17 EPS (37c)-(24c), consensus (31c) »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

VCRA

Vocera

$24.96

0.42 (1.71%)

16:41
04/27/17
04/27
16:41
04/27/17
16:41
Earnings
Vocera cuts FY17 adjusted EPS view to 2c-19c from 7c-24c, consensus 19c »

Backs FY17 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 17

    May

  • 30

    May

SSNC

SS&C

$37.65

0.34 (0.91%)

16:41
04/27/17
04/27
16:41
04/27/17
16:41
Earnings
SS&C sees FY17 adjusted revenue $1.66B-$1.69B, consensus $1.67B »

Reports FY17 adjusted net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

VCRA

Vocera

$24.96

0.42 (1.71%)

16:40
04/27/17
04/27
16:40
04/27/17
16:40
Earnings
Vocera reports Q1 adjusted EPS (5c), consensus (8c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 17

    May

  • 30

    May

BNFT

Benefitfocus

$30.85

0.9 (3.01%)

16:40
04/27/17
04/27
16:40
04/27/17
16:40
Earnings
Benefitfocus sees Q2 EPS (16c)-(13c), consensus (13c) »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

IRET

Investors Real Estate

$6.07

-0.09 (-1.46%)

16:40
04/27/17
04/27
16:40
04/27/17
16:40
Hot Stocks
Investors Real Estate announces CEO, senior management changes »

IRET, in a continuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNC

SS&C

$37.65

0.34 (0.91%)

16:39
04/27/17
04/27
16:39
04/27/17
16:39
Earnings
SS&C sees Q2 adjusted revenue $408M-$416M, consensus $412.69M »

Sees Q2 adjusted net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

MSTR

MicroStrategy

$192.49

-0.52 (-0.27%)

16:39
04/27/17
04/27
16:39
04/27/17
16:39
Earnings
MicroStrategy reports Q1 GAAP EPS $1.28, may not compare to consensus $1.47 »

Reports Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

ECOL

US Ecology

$48.45

-0.25 (-0.51%)

16:39
04/27/17
04/27
16:39
04/27/17
16:39
Earnings
US Ecology backs FY17 EPS $1.69-$1.93, consensus $1.79 »

"Overall, business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

SSNC

SS&C

$37.65

0.34 (0.91%)

16:38
04/27/17
04/27
16:38
04/27/17
16:38
Earnings
SS&C reports Q1 adjusted EPS 44c, consensus 44c »

Reports Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

INVA

Innoviva

$12.59

-0.26 (-2.02%)

16:38
04/27/17
04/27
16:38
04/27/17
16:38
Earnings
Innoviva reports Q1 adjusted EPS 19c, consensus 26c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

BNFT

Benefitfocus

$30.85

0.9 (3.01%)

16:38
04/27/17
04/27
16:38
04/27/17
16:38
Earnings
Benefitfocus reports Q1 EPS (11c), consensus (13c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

SRPT

Sarepta

$34.72

-0.14 (-0.40%)

16:38
04/27/17
04/27
16:38
04/27/17
16:38
Earnings
Sarepta raises FY17 revenue from above $80M to above $95M, consensus $97.78M »

"Based on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOL

US Ecology

$48.45

-0.25 (-0.51%)

16:37
04/27/17
04/27
16:37
04/27/17
16:37
Earnings
US Ecology reports Q1 EPS 24c, consensus 30c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

GOOGL

Alphabet Class A

$891.44

2.3 (0.26%)

16:37
04/27/17
04/27
16:37
04/27/17
16:37
Hot Stocks
Alphabet Class A shares rise 5% to $935 after earnings beat »

Alphabet Class A shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIQUY

Air Liquide

$24.16

-0.23 (-0.94%)

, LECO

Lincoln Electric

$89.58

-0.71 (-0.79%)

16:37
04/27/17
04/27
16:37
04/27/17
16:37
Hot Stocks
Air Liquide to sell welding unit to Lincoln Electric France »

Air Liquide (AIQUY)…

AIQUY

Air Liquide

$24.16

-0.23 (-0.94%)

LECO

Lincoln Electric

$89.58

-0.71 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

16:37
04/27/17
04/27
16:37
04/27/17
16:37
General news
Money Supply M2 Weekly Change data reported »

Week of 4/17 Money Supply…

16:36
04/27/17
04/27
16:36
04/27/17
16:36
General news
Fed Balance Sheet Level data reported »

Week of 4/26 Fed Balance…

RMD

ResMed

$72.85

1.1 (1.53%)

16:36
04/27/17
04/27
16:36
04/27/17
16:36
Earnings
ResMed reports Q3 non-GAAP EPS 71c, consensus 71c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.